Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients with Osteoporosis Caused by Glucocorticoids
Study of more than 800 men and women shows higher bone mineral densitywith Reclast than with risedronate, a current established therapy. Regulatory approval sought for treatment and prevention of glucocorticoidinduced osteoporosis in US. (PRWeb Apr 11, 2008)
Read the full story at [Please register to see this link Register]
[Please register to see this link
Register]